Exploring BMP9 and integrin alpha 10 as novel chondrogenic markers in human bone marrow-derived mesenchymal stem cells, chondroprogenitors, and chondrocytes: an immunohistochemistry study

Oct 5, 2025The Knee

BMP9 and integrin alpha 10 as new markers of cartilage cell development in human bone marrow stem cells and cartilage precursor and mature cells

AI simplified

Regenerative Health on OpenScience ↗PubMed ↗DOI ↗

Abstract

Integrin alpha 10 may serve as a valuable alternative marker to collagen type II for assessing chondrogenic differentiation in cartilage repair.

Immunohistochemical analysis showed collagen type II with a non-uniform expression pattern in differentiated pellets.
Integrin alpha 10 demonstrated a greater proportion of uptake and a more uniform distribution compared to collagen type II.
The observed spatial homogeneity of integrin alpha 10 could relate to its role as a receptor mediating cell-matrix interactions.
BMP9 did not demonstrate robust staining in the assessed samples.

AI simplified

BACKGROUND: Evaluating cartilage repair potential involves subjecting the cellular 3D pellets to chondrogenic differentiation and assessing their differentiation degree using immunohistochemical (IHC) studies. Collagen type II IHC staining stands as a key marker to evaluate mature chondrogenesis, but its non-uniform staining confounded by incomplete differentiation necessitates exploring alternative markers. This study explored the potential of BMP9 and Integrin Alpha 10 as novel early-stage chondrogenic markers in human bone marrow-derived mesenchymal stem cells (BM-MSCs), fibronectin assay derived chondroprogenitors (FAA-CPs), migratory chondroprogenitors (MCPs) and chondrocytes following differentiation.

METHODS: Three human articular cartilage samples and bone marrow aspirate from osteoarthritis patients were collected to isolate the BM-MSCs, FAA-CPs, MCPs and chondrocytes. Following their molecular characterization, differentiation assays were conducted followed by their confirmatory staining and IHC for BMP9 and Integrin alpha10.

RESULT: IHC analysis collagen type II revealed positive with a non-uniform pattern of expression. The same sections subjected to integrin alpha 10 IHC analysis exhibited a greater proportion of uptake and a more uniform distribution throughout the differentiated pellet, addressing a key limitation observed with ECM and collagen staining techniques. The spatial homogeneity observed could be attributed to the functional relevance of integrin alpha 10, a Collagen type II receptor which mediates cell-matrix interactions and is specifically expressed in chondrocytes, further underscoring its potential as an alternative marker. However, BMP9 did not display robust staining.

CONCLUSION: Integrin alpha 10 may serve as a valuable alternative or complementary marker to collagen type II for assessing chondrogenic differentiation, offering a more consistent spatial distribution.

Full Text

Full text is available at the source.

View full text (XML) ↗View full text ↗

Exploring BMP9 and integrin alpha 10 as novel chondrogenic markers in human bone marrow-derived mesenchymal stem cells, chondroprogenitors, and chondrocytes: an immunohistochemistry study

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week: